Literature DB >> 28460310

Synthesis, characterization, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide.

D I Ugwu1, U C Okoro2, P O Ukoha2, S Okafor3, A Ibezim3, N M Kumar4.   

Abstract

Sulphonamides and carboxamides have shown large number of pharmacological properties against different types of diseases among which is malaria. Twenty four new carboxamide derivatives bearing benzenesulphonamoyl alkanamides were synthesized and investigated for their in silico and in vitro antimalarial and antioxidant properties. The substituted benzenesulphonyl chlorides (1a-c) were treated with various amino acids (2a-h) to obtain the benzenesulphonamoyl alkanamides (3a-x) which were subsequently treated with benzoyl chloride to obtain the N-benzoylated derivatives (5a-f, i-n and q-v). Further reactions of the N-benzoylated derivatives or proline derivatives with 4-aminoacetophenone (6) using boric acid as a catalyst gave the sulphonamide carboxamide derivatives (7a-x) in excellent yields. The in vitro antimalarial studies showed that all synthesized compounds had antimalarial property. Compound 7k, 7c, 7l, 7s, and 7j had mean MIC value of 0.02, 0.03, 0.05, 0.06 and 0.08 μM respectively comparable with chloroquine 0.06 μM. Compound 7c was the most potent antioxidant agent with IC50 value of 0.045 mM comparable with 0.34 mM for ascorbic acid. In addition to the successful synthesis of the target molecules using boric acid catalysis, the compounds were found to have antimalarial and antioxidant activities comparable with known antimalarial and antioxidant drugs. The class of compounds reported herein have the potential of reducing oxidative stress arising from malaria parasite and chemotherapeutic agent used in the treatment of malaria.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antimalarial; Antioxidant; Carboxamides; Plasmepsin II; SAR; Sulphonamides

Mesh:

Substances:

Year:  2017        PMID: 28460310     DOI: 10.1016/j.ejmech.2017.04.029

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies.

Authors:  David I Ugwu; Uchechukwu C Okoro; Narendra K Mishra; Sunday N Okafor
Journal:  Lipids Health Dis       Date:  2018-05-22       Impact factor: 3.876

2.  New peptide derived antimalaria and antimicrobial agents bearing sulphonamide moiety.

Authors:  D I Ugwuja; U C Okoro; S S Soman; R Soni; S N Okafor; D I Ugwu
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

3.  Homology Modelling and Molecular Docking Studies of Selected Substituted Benzo[d]imidazol-1-yl)methyl)benzimidamide Scaffolds on Plasmodium falciparum Adenylosuccinate Lyase Receptor.

Authors:  Gbolahan O Oduselu; Olayinka O Ajani; Yvonne U Ajamma; Benedikt Brors; Ezekiel Adebiyi
Journal:  Bioinform Biol Insights       Date:  2019-07-31

4.  Prediction of potential inhibitors of SARS-CoV-2 using 3D-QSAR, molecular docking modeling and ADMET properties.

Authors:  Ayoub Khaldan; Soukaina Bouamrane; Fatima En-Nahli; Reda El-Mernissi; Khalil El Khatabi; Rachid Hmamouchi; Hamid Maghat; Mohammed Aziz Ajana; Abdelouahid Sbai; Mohammed Bouachrine; Tahar Lakhlifi
Journal:  Heliyon       Date:  2021-03-26

5.  Biological Activity Evaluation of Some New Benzenesulphonamide Derivatives.

Authors:  Florence Uchenna Eze; Uchechukwu Christopher Okoro; David Izuchukwu Ugwu; Sunday N Okafor
Journal:  Front Chem       Date:  2019-09-18       Impact factor: 5.221

6.  Novel anti-inflammatory and analgesic agents: synthesis, molecular docking and in vivo studies.

Authors:  David Izuchukwu Ugwu; Uchechukwu Christopher Okoro; Pius Onyeoziri Ukoha; Astha Gupta; Sunday N Okafor
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

7.  New sulphonamide pyrolidine carboxamide derivatives: Synthesis, molecular docking, antiplasmodial and antioxidant activities.

Authors:  Efeturi A Onoabedje; Akachukwu Ibezim; Uchechukwu C Okoro; Sanjay Batra
Journal:  PLoS One       Date:  2021-02-24       Impact factor: 3.240

8.  Fragment-based virtual screening discovers potential new Plasmodium PI4KIIIβ ligands.

Authors:  Akachukwu Ibezim; Mbanefo S Madukaife; Sochi C Osigwe; Nadja Engel; Ramanathan Karuppasamy; Fidele Ntie-Kang
Journal:  BMC Chem       Date:  2022-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.